VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CHMG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CHMGChemung Financial Corporation
$84.75$408M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. CHMG
  4. Financial Ratios

Chemung Financial Corporation (CHMG) Financial Ratios

Latest Ratios: P/E Ratio 10.7x · EV/EBITDA 9.7x · ROE 6.4%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

CHMG Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$408M$268M$233M$236M$215M$218M$163M$207M$200M$231M$173M
Enterprise Value$391M$251M$304M$240M$265M$216M$66M$97M$74M$274M$140M
P/E Ratio →10.6617.839.849.437.488.248.4713.2410.1722.2717.23
P/S Ratio4.082.852.422.412.282.461.972.592.413.012.38
P/B Ratio1.601.051.081.211.291.030.821.131.211.541.20
P/FCF23.006.138.897.756.226.205.878.117.6810.428.47
P/OCF8.985.907.817.636.146.135.697.847.199.767.82

P/E links to full P/E history page with 30-year chart

CHMG EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—2.663.172.452.802.440.791.220.893.571.93
EV / EBITDA9.6811.099.486.986.645.802.334.142.6614.257.15
EV / EBIT19.5912.5710.117.617.196.402.755.103.1318.679.73
EV / FCF—5.7211.627.887.666.162.363.812.8412.386.87

CHMG Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin95.3%95.3%100.0%96.7%100.6%100.0%94.9%92.6%96.2%88.3%96.7%
Operating Margin21.1%21.1%31.3%32.2%39.0%38.2%28.8%23.8%28.6%19.1%19.8%
Net Profit Margin16.0%16.0%24.6%25.5%30.4%29.9%23.2%19.5%23.7%9.7%13.8%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE6.4%6.4%11.5%13.8%15.2%12.9%10.1%9.0%12.5%5.1%7.1%
ROA0.6%0.6%0.9%0.9%1.1%1.1%0.9%0.9%1.1%0.4%0.6%
ROIC5.0%5.0%7.9%9.3%10.9%11.3%8.8%7.8%9.0%5.4%5.6%
ROCE5.6%5.6%11.6%13.4%16.2%14.2%10.5%9.5%13.2%8.5%8.3%

CHMG Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.020.020.550.210.640.120.060.070.030.500.29
Debt / EBITDA0.220.223.691.192.650.690.400.520.153.852.11
Net Debt / Equity—-0.070.330.020.30-0.01-0.49-0.60-0.760.29-0.23
Net Debt / EBITDA-0.79-0.792.230.121.25-0.04-3.46-4.67-4.522.26-1.67
Debt / FCF—-0.412.730.131.44-0.04-3.51-4.30-4.831.96-1.60
Interest Coverage0.440.440.560.825.069.875.993.015.804.793.76

Net cash position: cash ($23M) exceeds total debt ($5M)

CHMG Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.130.130.190.250.310.390.350.280.260.230.27
Quick Ratio0.130.130.190.250.310.390.350.280.260.230.27
Cash Ratio0.010.010.020.010.020.010.050.080.080.020.05
Asset Turnover—0.030.030.040.040.040.040.040.050.040.04
Inventory Turnover———————————
Days Sales Outstanding———————————

CHMG Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield1.6%2.4%3.2%2.5%2.7%2.4%3.1%2.4%2.5%2.1%2.8%
Payout Ratio41.9%41.9%31.1%23.4%20.1%20.1%26.0%32.2%25.3%66.2%48.6%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield9.4%5.6%10.2%10.6%13.4%12.1%11.8%7.6%9.8%4.5%5.8%
FCF Yield4.3%16.3%11.2%12.9%16.1%16.1%17.0%12.3%13.0%9.6%11.8%
Buyback Yield0.1%0.1%0.1%0.1%0.4%0.7%4.7%0.0%0.0%0.0%0.0%
Total Shareholder Yield1.6%2.5%3.3%2.6%3.1%3.2%7.7%2.4%2.5%2.1%2.8%
Shares Outstanding—$5M$5M$5M$5M$5M$5M$5M$5M$5M$5M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Reserve releases flattering earnings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Premium Multiple Rests on Earnings Recovery

Based on reported figures, CHMG trades at 1.60x book and roughly 27x trailing earnings, while forward P/E compresses to about 10x, implying the market is pricing a sustained step-up in normalized profitability.

The price-to-book of 1.60x sits within the range of the peer group, where AROW trades at 1.47x and CFFI at 1.30x, suggesting the market is not awarding CHMG a clear franchise premium. The gap between trailing P/E of 27x and forward P/E of 10x is largely a function of the recent provision benefit and the 2025Q2 non-interest income loss, so the forward figure should be treated as contingent on those items not recurring. Investors should monitor whether tangible book value growth of roughly 5% per quarter can persist without relying on reserve releases.

ROE Recovery Driven by Credit Reversal

According to reported figures, CHMG's ROE improved from 2.5% in 2024Q2 to 4.7% in 2026Q3, but the decomposition shows the latest step-up coincides with a negative provision rather than a durable improvement in margin.

ROA remains near 0.3% and net interest margin sits around 0.9%, so the leverage multiple, with equity at roughly 10% of assets, is doing much of the work in lifting ROE. Fee income is volatile, ranging from roughly 20% of revenue in most quarters to a deeply negative reading in 2025Q2, which makes the non-interest income contribution an unreliable base. The profitability picture suggests earnings quality warrants further investigation before the recent ROE level is treated as a run rate.

Thin Spread Offset by Cost Discipline

As reported in financial statements, CHMG's net interest margin has held between 0.6% and 0.9% across ten quarters, while the efficiency ratio improved from 68.4% to 56.5%, indicating cost control is doing the heavier lifting on profitability.

A sub-one-percent NIM leaves limited cushion against funding cost pressure, so the operating economics depend on expense management rather than spread expansion. The efficiency ratio trend is favorable, though the 2026Q2 reading of 2.5% reflects distortion from the non-interest income loss rather than an operating improvement. Operating leverage appears to be building, but the data suggests the efficiency gain may be partly flattered by revenue volatility.

Equity Build Outpaces Asset Growth

Based on CHMG's reported figures, equity-to-assets rose from about 0.07 to roughly 0.10 over ten quarters, which appears to create a meaningfully stronger capital cushion, though regulatory capital ratio detail is not provided in the supplied data.

The equity ratio expansion indicates retained earnings are building capital faster than the balance sheet is growing, a dynamic that typically supports future capacity for growth or capital return. Because CET1, Tier 1, and total capital ratios are not included in the supplied dataset, the regulatory headroom cannot be confirmed and should be verified against filings. Investors should treat the rising equity ratio as directionally supportive while recognizing that a portion of the build reflects provision benefits that may not repeat.

Provision Reversal Masks Credit Cost Trend

According to reported figures, CHMG's loan loss provision moved from roughly $1.1M per quarter through 2025 to a net benefit of -$2.6M in 2026Q3, materially lowering reported credit costs and raising questions about reserve adequacy.

A shift from consistent provisioning to a net release at the same time loan growth continues suggests reserve coverage may be drawn down faster than credit conditions justify. Non-performing loan, charge-off, and reserve coverage ratios are not included in the supplied data, so adequacy cannot be assessed directly. The pattern warrants further investigation into whether the release reflects genuine improvement or a judgment change.

Provision Benefit Overstates Core Earnings

Based on reported figures, the most misleading metric for CHMG is trailing ROE, since the 2026Q3 reading of 4.7% benefited from a -$2.6M provision that may not be repeatable and could overstate underlying profitability.

Using the 2026Q3 ROE to value the franchise would capitalize a one-time reserve release as recurring earnings, which obscures the 2025 run rate near 3.1% to 3.2%. A more reliable approach would normalize provisions to the 2025 average and examine ROTCE, which strips out the intangible-heavy equity base and better reflects returns on tangible capital. Investors should monitor whether provision expense returns to positive territory in coming quarters.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open CHMG Terminal

CHMG Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CHMG — Frequently Asked Questions

Quick answers to the most common questions about buying CHMG stock.

What is Chemung Financial Corporation's P/E ratio?

Chemung Financial Corporation's current P/E ratio is 10.7x. The historical average is 13.3x. This places it at the 34th percentile of its historical range.

What is Chemung Financial Corporation's EV/EBITDA?

Chemung Financial Corporation's current EV/EBITDA is 9.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.3x.

What is Chemung Financial Corporation's ROE?

Chemung Financial Corporation's return on equity (ROE) is 6.4%. The historical average is 9.7%.

Is CHMG stock overvalued?

Based on historical data, Chemung Financial Corporation is trading at a P/E of 10.7x. This is at the 34th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Chemung Financial Corporation's dividend yield?

Chemung Financial Corporation's current dividend yield is 1.55% with a payout ratio of 41.9%.

What are Chemung Financial Corporation's profit margins?

Chemung Financial Corporation has 95.3% gross margin and 21.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does Chemung Financial Corporation have?

Chemung Financial Corporation's Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.